This might be partially attributed to the fact that sPDL2 could derive from the cleavage of membrane-bound PDL2, tumor exosomes, or activated macrophages [33], which could then interfere with the binding of PD1and PDL1/PDL2 in TME, thereby affecting anti-tumor immunity. This evidence concerns the gene CD274 and neoplasm.